Загрузка...
Effect of Denosumab on Bone Mineral Density of Hematopoietic Stem Cell Transplantation Recipients
PURPOSE: Denosumab is a monoclonal antibody that prevents the development of osteoclasts. The effect of denosumab in solid organ transplant recipients has been elucidated, but its effect in haematopoietic stem cell transplantation recipients has not been studied yet. The aim of this study was to det...
Сохранить в:
| Опубликовано в: : | Int J Endocrinol |
|---|---|
| Главные авторы: | , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Hindawi
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7218957/ https://ncbi.nlm.nih.gov/pubmed/32454821 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/3410921 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|